Repeated cocaine exposure attenuates the ability of 5-hydroxytryptamine to release striatal dopamine in vivo

By Norton C.S.   Galloway M.P.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 323-326

Elsevier

Access to resources Recommend Favorite

Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine

By Reimann W.   Schneider F.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 199-203

Elsevier

Access to resources Recommend Favorite

Dopamine and 5-hydroxytryptamine selectively potentiate neuronal type ATP receptor channels

By Nakazawa K.   Ohno Y.  

European Journal of Pharmacology, Vol. 296, Iss. 1, 1996-01 ,pp. : 119-122

Elsevier

Access to resources Recommend Favorite

Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser

By Gobbi M.   Mennini T.  

European Journal of Pharmacology, Vol. 370, Iss. 1, 1999-04 ,pp. : 23-26

Elsevier

Access to resources Recommend Favorite

5-HT-moduline, a 5-HT 1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis

By Bentue-Ferrer D.   Reymann J.-M.   Rousselle J.-C.   Massot O.   Bourin M.   Allain H.   Fillion G.  

European Journal of Pharmacology, Vol. 358, Iss. 2, 1998-10 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite